These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 11297518)

  • 1. Breast cancer. Cyr61 is overexpressed, estrogen-inducible, and associated with more advanced disease.
    Xie D; Miller CW; O'Kelly J; Nakachi K; Sakashita A; Said JW; Gornbein J; Koeffler HP
    J Biol Chem; 2001 Apr; 276(17):14187-94. PubMed ID: 11297518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and regulation of Cyr61 in human breast cancer cell lines.
    Tsai MS; Bogart DF; Li P; Mehmi I; Lupu R
    Oncogene; 2002 Jan; 21(6):964-73. PubMed ID: 11840342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyr61, a member of the CCN family, is required for MCF-7 cell proliferation: regulation by 17beta-estradiol and overexpression in human breast cancer.
    Sampath D; Winneker RC; Zhang Z
    Endocrinology; 2001 Jun; 142(6):2540-8. PubMed ID: 11356703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyr61 promotes breast tumorigenesis and cancer progression.
    Tsai MS; Bogart DF; Castañeda JM; Li P; Lupu R
    Oncogene; 2002 Nov; 21(53):8178-85. PubMed ID: 12444554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features.
    Xie D; Nakachi K; Wang H; Elashoff R; Koeffler HP
    Cancer Res; 2001 Dec; 61(24):8917-23. PubMed ID: 11751417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WISP-2 gene in human breast cancer: estrogen and progesterone inducible expression and regulation of tumor cell proliferation.
    Banerjee S; Saxena N; Sengupta K; Tawfik O; Mayo MS; Banerjee SK
    Neoplasia; 2003; 5(1):63-73. PubMed ID: 12659671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyr61, a member of CCN family, is a tumor suppressor in non-small cell lung cancer.
    Tong X; Xie D; O'Kelly J; Miller CW; Muller-Tidow C; Koeffler HP
    J Biol Chem; 2001 Dec; 276(50):47709-14. PubMed ID: 11598125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cloning and characterization of the human WISP-2/CCN5 gene promoter reveal its upregulation by oestrogens.
    Fritah A; Redeuilh G; Sabbah M
    J Endocrinol; 2006 Dec; 191(3):613-24. PubMed ID: 17170219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and function of CYR61, an angiogenic factor, in breast cancer cell lines and tumor biopsies.
    Tsai MS; Hornby AE; Lakins J; Lupu R
    Cancer Res; 2000 Oct; 60(20):5603-7. PubMed ID: 11059746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trefoil factor 3 is oncogenic and mediates anti-estrogen resistance in human mammary carcinoma.
    Kannan N; Kang J; Kong X; Tang J; Perry JK; Mohankumar KM; Miller LD; Liu ET; Mertani HC; Zhu T; Grandison PM; Liu DX; Lobie PE
    Neoplasia; 2010 Dec; 12(12):1041-53. PubMed ID: 21170268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyr61 expression confers resistance to apoptosis in breast cancer MCF-7 cells by a mechanism of NF-kappaB-dependent XIAP up-regulation.
    Lin MT; Chang CC; Chen ST; Chang HL; Su JL; Chau YP; Kuo ML
    J Biol Chem; 2004 Jun; 279(23):24015-23. PubMed ID: 15044484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role for HER2/neu and HER3 in fulvestrant-resistant breast cancer.
    Osipo C; Meeke K; Cheng D; Weichel A; Bertucci A; Liu H; Jordan VC
    Int J Oncol; 2007 Feb; 30(2):509-20. PubMed ID: 17203234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
    Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
    Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth.
    Babic AM; Kireeva ML; Kolesnikova TV; Lau LF
    Proc Natl Acad Sci U S A; 1998 May; 95(11):6355-60. PubMed ID: 9600969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen enhances myoepithelial cell suppression of human breast carcinoma progression in vitro by two different effector mechanisms.
    Shao ZM; Radziszewski WJ; Barsky SH
    Cancer Lett; 2000 Sep; 157(2):133-44. PubMed ID: 10936673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
    Pink JJ; Jordan VC
    Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer.
    Osborne CK; Coronado-Heinsohn EB; Hilsenbeck SG; McCue BL; Wakeling AE; McClelland RA; Manning DL; Nicholson RI
    J Natl Cancer Inst; 1995 May; 87(10):746-50. PubMed ID: 7563152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of antiestrogens and aromatase inhibitor on basal growth of the human breast cancer cell line MCF-7 in serum-free medium.
    Jensen J; Kitlen JW; Briand P; Labrie F; Lykkesfeldt AE
    J Steroid Biochem Mol Biol; 2003 Mar; 84(4):469-78. PubMed ID: 12732292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and regulation of estrogen receptor beta in human breast tumors and cell lines.
    Vladusic EA; Hornby AE; Guerra-Vladusic FK; Lakins J; Lupu R
    Oncol Rep; 2000; 7(1):157-67. PubMed ID: 10601611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor is a target gene for estrogen receptor and contributes to breast cancer progression.
    Applanat MP; Buteau-Lozano H; Herve MA; Corpet A
    Adv Exp Med Biol; 2008; 617():437-44. PubMed ID: 18497067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.